1 / 41

PHARMACOKINETICS

PHARMACOKINETICS. “What the body does to the drug”. Elimination. Pharmacokinetics (PK). The study of the disposition of a drug The disposition of a drug includes the processes of ADME A bsorption D istribution M etabolism E xcretion T oxicity. ADMET. DRUG R&D.

emma
Download Presentation

PHARMACOKINETICS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PHARMACOKINETICS “What the body does to the drug”

  2. Elimination Pharmacokinetics (PK) • The study of the disposition of a drug • The disposition of a drug includes the processes of ADME • Absorption • Distribution • Metabolism • Excretion • Toxicity

  3. ADMET

  4. DRUG R&D • Drug discovery and development • 10-15 years to develop a new medicine • Likelihood of success: 10% • Cost $800 million – 1 billion dollars (US)

  5. Why drugs fail

  6. Importance of PK studies • Patients may suffer: • Toxic drugs may accumulate • Useful drugs may have no benefit because doses are too small to establish therapy • A drug can be rapidly metabolized.

  7. Routes Of Administration Routes Of Drug Administration Enteral Parenteral Injection Topical Respiratory Rectal Oral

  8. Absorption • The process by which drug proceeds from the site of administration to the site of measurement (blood stream) within the body. • Necessary for the production of a therapeutic effect. • Most drugs undergo gastrointestinal absorption. This is extent to which drug is absorbed from gut lumen into portal circulation • Exception: IV drug administration

  9. IV vs Oral

  10. The Process • Absorption relies on • Passage through membranes to reach the blood • passive diffusion of lipid soluble species.

  11. The Rule of Five - formulation • There are more than 5 H-bond donors. • The molecular weight is over 500. • The LogP is over 5. • There are more than 10 H-bond acceptors. Poor absorption or permeation are more likely when:

  12. Absorption & Ionization Non-ionised drug More lipid solubledrug Diffuse across cell membranes more easily

  13. First Pass Metabolism • Bioavailability: the fraction of the administered dose reaching the systemic circulation Destroyed in gut Destroyed by liver Not absorbed Destroyed by gut wall to systemic circulation Dose

  14. Determination of bioavailability • A drug given by the intravenous route will have an absolute bioavailability of 1 (F=1 or 100% bioavavailable) • While drugs given by other routes usually have an absolute bioavailability of less than one. • The absolute bioavailability is the area under curve (AUC) non-intravenous divided by AUC intravenous .

  15. The therapeutic index is the degree of separation between toxic and therapeutic doses. Relationship Between Dose, Therapeutic Effect and Toxic Effect. The Therapeutic Index is Narrow for Most Cancer Drugs 100× 10× Toxicity

  16. Distribution • The movement of drug from the blood to and from the tissues

  17. DISTRIBUTION • Determined by: • • partitioning across various membranes • •binding to tissue components • •binding to blood components (RBC, plasma protein) • •physiological volumes

  18. DISTRIBUTION • All of the fluid in the body (referred to as the total body water), in which a drug can be dissolved, can be roughly divided into three compartments: • intravascular (blood plasma found within blood vessels) • interstitial/tissue (fluid surrounding cells) • intracellular (fluid within cells, i.e. cytosol) • The distribution of a drug into these compartments is dictated by it's physical and chemical properties

  19. TOTAL BODY WATER Vascular 3 L 4% BW Extravascular 9 L 13% BW Intracellular 28 L 41% BW

  20. Distribution • Apparent volume of distribution (Vd) = Amt of drug in body/plasma drug conc • VOLUME OF DISTRIBUTION FOR SOME DRUGS DRUG Vd (L) cocaine 140 clonazepam 210 amitriptyline 1050 amiodarone ~5000

  21. Factors affecting drugs Vd • Blood flow: rate varies widely as function of tissue Muscle = slow Organs = fast • Capillary structure: •Most capillaries are “leaky” and do not impede diffusion of drugs •Blood-brain barrier formed by high level of tight junctions between cells •BBB is impermeable to most water-soluble drugs

  22. Blood Brain Barrier • Disruption by osmotic means • Use of endogenous transport systems • Blocking of active efflux transporters • Intracerebral implantation • Etc

  23. Plasma Protein Binding • Many drugs bind to plasma proteins in the blood steam • Plasma protein binding limits distribution. • A drug that binds plasma protein diffuses less efficiently, than a drug that doesn’t.

  24. Physiochemical properties-Po/w • The Partition coefficient (Po/w) and can be used to determine where a drug likes to go in the body • Any drug with a Po/w greater than 1(diffuse through cell membranes easily) is likely be found throughout all three fluid compartments • Drugs with low Po/w values (meaning that they are fairly water-soluble) are often unable to cross and require more time to distribute throughout the rest of the body

  25. Physiochemical Properties-Size of drug • The size of a drug also dictates where it can go in the body. • Most drugs : 250 and 450 Da MW • Tiny drugs (150-200 Da) with low Po/w values like caffeine can passively diffuse through cell membranes • Antibodies and other drugs range into the thousands of daltons • Drugs >200 Da with low Po/w values cannot passively cross membranes- require specialized protein-based transmembrane transport systems- slower distribution • Drugs < thousand daltons with high Po/w values-simply diffuse between the lipid molecules that make up membranes, while anything larger requires specialized transport.

  26. Elimination • The irreversible removal of the parent drugs from the body Elimination Excretion Drug Metabolism (Biotransformation)

  27. Drug Metabolism • The chemical modification of drugs with the overall goal of getting rid of the drug • Enzymes are typically involved in metabolism Metabolism Excretion More polar (water soluble) Drug Drug

  28. METABOLISM • From 1898 through to 1910 heroin was marketed as a non-addictive morphine substitute and cough medicine for children. Bayer marketed heroin as a cure for morphine addiction • Heroin is converted to morphine when metabolized in the liver

  29. Phases of Drug Metabolism • Phase I Reactions • Convert parent compound into a more polar (=hydrophilic) metabolite by adding or unmasking functional groups (-OH, -SH, -NH2, -COOH, etc.) eg. oxidation • Often these metabolites are inactive • May be sufficiently polar to be excreted readily

  30. Phases of metabolism • Phase II Reactions • Conjugation with endogenous substrate to further increase aqueous solubility • Conjugation with glucoronide, sulfate, acetate, amino acid

  31. Mostly occurs in the liver because all of the blood in the body passes through the liver

  32. The Most Important Enzymes • Microsomal cytochrome P450 monooxygenase family of enzymes, which oxidize drugs • Act on structurally unrelated drugs • Metabolize the widest range of drugs.

  33. CYP family of enzymes • • Found in liver, small intestine, lungs, kidneys, placenta • • Consists of > 50 isoforms • • Major source of catalytic activity for drug oxidation • • It’s been estimated that 90% or more of human drug oxidation can be attributed to 6 main enzymes: • • CYP1A2 • CYP2D6 • • CYP2C9 • CYP2E1 • • CYP2C19 • CYP3A4 • In different people and different populations, activity of CYP oxidases differs.

  34. Inhibitors and inducers of microsomal enzymes • Inhibitors: cimetidine prolongs action of drugs or inhibits action of those biotransformed to active agents (pro-drugs) • Inducers: barbiturates, carbamazepine shorten action of drugs or increase effects of those biotransformed to active agents • Blockers: acting on non-microsomal enzymes (MAOI, anticholinesterase drugs)

  35. Phase II • Main function of phase I reactions is to prepare chemicals for phase II metabolism and subsequent excretion • Phase II is the true “detoxification” step in the metabolism process.

  36. Phase II reactions • Conjugation reactions • Glucuronidation (on -OH, -COOH, -NH2, -SH groups) • Sulfation (on -NH2, -SO2NH2, -OH groups) • Acetylation (on -NH2, -SO2NH2, -OH groups) • Amino acid conjugation (on -COOH groups) • Glutathione conjugation (to epoxides or organic halides) • Fatty acid conjugation (on -OH groups) • Condensation reactions

  37. Glucuronidation • Conjugation to a-d-glucuronic acid • Quantitatively the most important phase II pathway for drugs and endogenous compounds • Products are often excreted in the bile

  38. Phase I and II - Summary • Products are generally more water soluble • These reactions products are ready for (renal) excretion • There are many complementary, sequential and competing pathways • Phase I and Phase II metabolism are a coupled interactive system interfacing with endogenous metabolic pathways

  39. Excretion • The main process that body eliminates "unwanted" substances. • Most common route - biliary or renal • Other routes - lung (through exhalation), skin (through perspiration) etc. • Lipophilic drugs may require several metabolism steps before they are excreted

  40. ADME - Summary

More Related